Blemish Control Blotting Paper
NDC Package 76449-050-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Blemish Control Blotting Paper is take a piece of NYX Blotting Paper and dab over oily areas. Marketed by Nyx Los Angeles Inc., this product is identified by NDC 76449-050 and is authorized under FDA application part358H.

Identification & Billing

NDC Package Code
76449-050-01
Package Description
100 STRIP in 1 PACKAGE
Product Code
76449-050
11-Digit Billing Format
76449005001

Clinical Specifications

Proprietary Name
Blemish Control Blotting Paper
Dosage Form
-
Usage Information
Take a piece of NYX Blotting Paper and dab over oily areas

Regulatory & Marketing

Labeler Name
Nyx Los Angeles Inc.
FDA Application #
part358H
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
12-15-2011
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76449-050-01 identifies a specific commercial package of 100 strip in 1 package of Blemish Control Blotting Paper, labeled by Nyx Los Angeles Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nyx Los Angeles Inc. on December 15, 2011. The current certification is valid through December 31, 2017.

How is this Nyx Los Angeles Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76449005001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76449-050-01
11-Digit CMS (5-4-2)
76449-0050-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.